Literature DB >> 32715402

HBO-PC Promotes Locomotor Recovery by Reducing Apoptosis and Inflammation in SCI Rats: The Role of the mTOR Signaling Pathway.

Huiqiang Chen1, Guoshen Xu2, You Wu1, Xinyu Wang1, Fei Wang1, Ying Zhang3.   

Abstract

Hyperbaric oxygen preconditioning (HBO-PC) has beneficial effects on the promotion of locomotor recovery by reducing apoptosis and inflammation after traumatic spinal cord injury (SCI). The mammalian target of rapamycin (mTOR) signaling pathway has been implicated in apoptosis and inflammation in many pathophysiological conditions. However, whether HBO-PC improves traumatic SCI-induced locomotor dysfunction by regulating the mTOR signaling pathway and its downstream molecules remains unknown. In the present study, we found that HBO-PC significantly promoted SCI-induced hind-limb locomotor recovery and increased the amplitude and potential of motor evoked potential. Magnetic resonance imaging showed that spinal cavitation or atrophy caused by SCI was obviously alleviated by HBO-PC therapy. Histological analysis showed that the changes in spinal cord neural structure in SCI rats were markedly restored by HBO-PC treatment. Western blot analysis showed that the SCI-induced enhanced levels of p-mTOR, inflammatory cytokines and apoptosis in the spinal cord were abrogated after administration of HBO-PC. Furthermore, intrathecal administration of an mTOR agonist reversed the effects of HBO-PC on locomotor function recovery, p-NF-κB p65 and p-p70S6K levels, inflammation and apoptosis. These findings indicated a new mechanism by which HBO-PC therapy suppressed inflammation and apoptosis through inactivation of the mTOR signaling pathway, which contributed to motor disability in SCI rats.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Apoptosis; HBO-PC; Inflammation; Spinal cord injury; mTOR

Mesh:

Substances:

Year:  2020        PMID: 32715402     DOI: 10.1007/s10571-020-00921-3

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  2 in total

1.  Topical application of TNF-alpha antiserum attenuates spinal cord trauma induced edema formation, microvascular permeability disturbances and cell injury in the rat.

Authors:  H S Sharma; T Winkler; E Stålberg; T Gordh; P Alm; J Westman
Journal:  Acta Neurochir Suppl       Date:  2003

2.  The role of multiple hyperbaric oxygenation in expanding therapeutic windows after acute spinal cord injury in rats.

Authors:  Lixin Huang; Maheshkumar P Mehta; Anil Nanda; John H Zhang
Journal:  J Neurosurg       Date:  2003-09       Impact factor: 5.115

  2 in total
  5 in total

1.  Identification of Ferroptotic Genes in Spinal Cord Injury at Different Time Points: Bioinformatics and Experimental Validation.

Authors:  Yu Kang; Qiangwei Li; Rui Zhu; Shuang Li; Xin Xu; Xuanming Shi; Zongsheng Yin
Journal:  Mol Neurobiol       Date:  2022-07-07       Impact factor: 5.682

2.  The mechanism by which hyperbaric oxygen treatment alleviates spinal cord injury: genome-wide transcriptome analysis.

Authors:  Zhen-Cheng Sun; Fang Liang; Jing Yang; Yong Hai; Qing-Jun Su; Xue-Hua Liu
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

3.  Hyaluronic Acid Hydrogels Hybridized With Au-Triptolide Nanoparticles for Intraarticular Targeted Multi-Therapy of Rheumatoid Arthritis.

Authors:  Chenxi Li; Rui Liu; Yurong Song; Youwen Chen; Dongjie Zhu; Liuchunyang Yu; Qingcai Huang; Zhengjia Zhang; Zeyu Xue; Zhenglai Hua; Cheng Lu; Aiping Lu; Yuanyan Liu
Journal:  Front Pharmacol       Date:  2022-05-27       Impact factor: 5.988

Review 4.  Quercetin Can Improve Spinal Cord Injury by Regulating the mTOR Signaling Pathway.

Authors:  Xichen Wang; Yuke Fu; Benson O A Botchway; Yufeng Zhang; Yong Zhang; Tian Jin; Xuehong Liu
Journal:  Front Neurol       Date:  2022-05-20       Impact factor: 4.086

Review 5.  Survey of Molecular Mechanisms of Hyperbaric Oxygen in Tissue Repair.

Authors:  Joerg Lindenmann; Christian Smolle; Lars-Peter Kamolz; Freyja Maria Smolle-Juettner; Wolfgang F Graier
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.